Paper Details 
Original Abstract of the Article :
Tropane alkaloids, mainly hyoscyamine and scopolamine, are widely used in medicine due to their anticholinergic activity. Scopolamine has a higher demand being the more valuable alkaloid due to its fewer side effects and higher physiological activity. Anisodamine (6beta-hydroxyhyoscyamine) is the in...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2430943/

データ提供:米国国立医学図書館(NLM)

Hyoscyamine 6beta-Hydroxylase: A Key to Scopolamine Production

Tropane alkaloids, like hyoscyamine and scopolamine, have long been used in medicine due to their anticholinergic properties. Scopolamine, in particular, is highly valued for its effectiveness and reduced side effects. This research explores the potential of producing scopolamine using a biocatalytic approach, focusing on Hyoscyamine 6beta-hydroxylase, the enzyme responsible for converting hyoscyamine to scopolamine. Think of this research as a quest to unlock the secrets of a hidden treasure, revealing the pathway to producing valuable medicinal compounds through nature's own processes.

A Biocatalytic Approach to Scopolamine Production

The researchers successfully expressed the gene encoding Hyoscyamine 6beta-hydroxylase in Saccharomyces cerevisiae, a common yeast. This achievement paves the way for developing a cost-effective and sustainable method for producing scopolamine using a biocatalytic process. Imagine this as cultivating a thriving oasis in the desert, where the yeast acts as a valuable resource for producing a crucial medicinal compound.

Potential for New Medical Applications

The research also highlights the potential of Anisodamine, an intermediate in the conversion of hyoscyamine to scopolamine, for medical applications. This discovery opens up new avenues for exploring the therapeutic potential of this valuable compound. It's like finding a hidden spring in the desert, revealing new possibilities for utilizing its resources.

Dr. Camel's Conclusion

This research demonstrates the potential of biocatalysis for producing valuable medicinal compounds. The successful expression of Hyoscyamine 6beta-hydroxylase in yeast offers a promising avenue for sustainable and cost-effective scopolamine production. As a curious camel in the desert of medicinal chemistry, I am intrigued by the potential of this biocatalytic approach to address the growing demand for this important alkaloid.

Date :
  1. Date Completed 2012-10-02
  2. Date Revised 2021-10-20
Further Info :

Pubmed ID

18505565

DOI: Digital Object Identifier

PMC2430943

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.